Steroid analogs and characterization and treatment methods

Details for Australian Patent Application No. 2005330504 (hide)

Owner Harbor Biosciences, Inc.

Inventors Reading, Christopher; Dowding, Charles; Frincke, James

Agent Griffith Hack

Pub. Number AU-B-2005330504

PCT Pub. Number WO2006/110172

Priority 60/614,869 29.09.04 US

Filing date 29 September 2005

Wipo publication date 19 October 2006

Acceptance publication date 28 October 2010

International Classifications

A61K 49/00 (2006.01) Preparations for testing

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/110172 Priority application(s): WO2006/110172

19 April 2007 Change of Name(s) of Applicant(s), Section 104

  Hollis-Eden Pharmaceuticals. Inc. The name of the applicant has been changed to Hollis-Eden Pharmaceuticals, Inc.

10 June 2010 Alteration of Name

  The name of the applicant has been altered to Harbor Biosciences, Inc. 2006

28 October 2010 Application Accepted

  Published as AU-B-2005330504

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005330507-Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor

2005330494-Artificial dielectrics using nanostructures